Management of common clinical problems experienced by survivors of cancer

J Emery, P Butow, J Lai-Kwon, L Nekhlyudov… - The Lancet, 2022 - thelancet.com
Improvements in early detection and treatment have led to a growing prevalence of survivors
of cancer worldwide. Models of care fail to address adequately the breadth of physical …

Comorbid depression in medical diseases

SM Gold, O Köhler-Forsberg, R Moss-Morris… - Nature Reviews …, 2020 - nature.com
Depression is one of the most common comorbidities of many chronic medical diseases
including cancer and cardiovascular, metabolic, inflammatory and neurological disorders …

[HTML][HTML] Depression and anxiety among people living with and beyond cancer: a growing clinical and research priority

CL Niedzwiedz, L Knifton, KA Robb, SV Katikireddi… - BMC cancer, 2019 - Springer
Background A cancer diagnosis can have a substantial impact on mental health and
wellbeing. Depression and anxiety may hinder cancer treatment and recovery, as well as …

Distress management, version 3.2019, NCCN clinical practice guidelines in oncology

MB Riba, KA Donovan, B Andersen, II Braun… - Journal of the National …, 2019 - jnccn.org
Distress is defined in the NCCN Guidelines for Distress Management as a multifactorial,
unpleasant experience of a psychologic (ie, cognitive, behavioral, emotional), social …

Suicide risk and mortality among patients with cancer

M Heinrich, L Hofmann, H Baurecht, PM Kreuzer… - Nature medicine, 2022 - nature.com
Despite substantial progress in cancer therapy in recent decades, patients with cancer
remain at high suicide risk. Data from individual studies have not been comprehensively …

Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial

S Ross, A Bossis, J Guss… - Journal of …, 2016 - journals.sagepub.com
Background: Clinically significant anxiety and depression are common in patients with
cancer, and are associated with poor psychiatric and medical outcomes. Historical and …

Classical psychedelics for the treatment of depression and anxiety: A systematic review

S Muttoni, M Ardissino, C John - Journal of affective disorders, 2019 - Elsevier
Background Depression and anxiety are prevalent psychiatric disorders that carry significant
morbidity. Pharmacological and psychosocial interventions are used to manage these …

Management of anxiety and depression in adult survivors of cancer: ASCO guideline update

BL Andersen, C Lacchetti, K Ashing… - Journal of Clinical …, 2023 - ascopubs.org
PURPOSE To update the American Society of Clinical Oncology guideline on the
management of anxiety and depression in adult cancer survivors. METHODS A …

Psychedelics for the treatment of depression, anxiety, and existential distress in patients with a terminal illness: a systematic review

N Schimmers, JJ Breeksema, SY Smith-Apeldoorn… - …, 2022 - Springer
Background Terminally ill patients may experience existential distress, depression, or
anxiety, limiting quality of life in the final stage. Existing psychotherapeutic or …

[HTML][HTML] Classic serotonergic psychedelics for mood and depressive symptoms: a meta-analysis of mood disorder patients and healthy participants

NL Galvão-Coelho, W Marx, M Gonzalez, J Sinclair… - …, 2021 - Springer
Rationale Major depressive disorder is one of the leading global causes of disability, for
which the classic serotonergic psychedelics have recently reemerged as a potential …